Global

Psychiatry Experts

Benedicto Crespo Facorro


HOSPITAL UNIVERSITARIO MARQUES DE VALDECILLA
Sant Pau Biomedical Research Institute
Spain

Biography

Benedicto Crespo-Facorro is associate Professor of Psychiatry and deputy head of the Department of Medicine and Psychiatry, University of Cantabria, Santander. He trained in Psychiatry at the Hospital Clinico San Carlos, Complutense University, Madrid and after his clinical training was awarded by Spanish Institute of Health Carlos III a two-year research Fellowship in schizophrenia research at the Mental Health Clinical Research Center, University of Iowa, USA. He is currently Director of Cantabria Psychoses First Episode Service (PAFIP) and principal Investigator of the research group CIBERSAM G26. He is on the editorial board of European, American and Asiatic journals. Areas of interest include the clinical, cognitive and biological basis of schizophrenia, in particular the study of imaging genetics, metabolomic and genomics of non-affective psychoses in early phases of illness. Treatment studies focus on treatment effectiveness and safety of antipsychotics, and aspects of medical and mental comorbidity of schizophrenia. He has received several scientific awards: the annual Young Investigator Award from the American Neuropsychiatric Association (ANPA, 1997), Young Investigator Award of the International Congress on Schizophrenia Research (ICOSR, 2001), Reference Researcher in Psychiatry Award from de Sociedad Española de Psquiatría Biológica (SEPB, 2006) and Bank of Sabadell ¨National Award of Research in Biomedicine” (2007).Over the period 2000-2013, his group published over 140 papers on MEDLINE in leading psychiatric, neuroscience and general medical journals, h factor 32.

Research Interest

Psychiatry

Publications

  • Morlán-Coarasa MJ1, Arias-Loste MT2, Ortiz-García de la Foz V3, Martínez-García O3, Alonso-Martín C2, Crespo J2, Romero-Gómez M4, Fábrega E2, Crespo-Facorro B5. Incidence of non-alcoholic fatty liver disease and metabolic dysfunction in first episode schizophrenia and related psychotic disorders: a 3-year prospective randomized interventional study. Psychopharmacology (Berl). 2016 Dec;233(23-24):3947-3952.

Global Experts from Spain

Global Experts in Subject

Share This Profile
Recent Expert Updates
  • Matthew L Stone
    Matthew L Stone
    pediatrics
    University of Virginia Health System; Charlottesville, VA
    United States of America
  • Dr.   Matthew
    Dr. Matthew
    pediatrics
    University of Virginia Health System; Charlottesville, VA
    United States of America
  • Dr.  L Stone Matthew
    Dr. L Stone Matthew
    pediatrics
    University of Virginia Health System; Charlottesville, VA
    United States of America
  • Dr.  L Stone
    Dr. L Stone
    pediatrics
    University of Virginia Health System; Charlottesville, VA
    United States of America
  • Dr. Matthew L Stone
    Dr. Matthew L Stone
    pediatrics
    University of Virginia Health System; Charlottesville, VA
    United States of America
  • Dr.  R Sameh
    Dr. R Sameh
    pediatrics
    King Abdul Aziz University
    United Arab Emirates
  • Dr.   R Ismail,
    Dr. R Ismail,
    pediatrics
    King Abdul Aziz University
    United Arab Emirates
  • Sameh R Ismail,
    Sameh R Ismail,
    pediatrics
    King Abdul Aziz University
    United Arab Emirates
  • Dr.   Sameh R Ismail,
    Dr. Sameh R Ismail,
    pediatrics
    King Abdul Aziz University
    United Arab Emirates
  • Dr.   William
    Dr. William
    pediatrics
    Maimonides Medical Center
    United States of America